Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “TEVA PHARMACEUTICAL INDUSTRIES, LTD.”

302 pharma patents match "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 302
Index total 30,257
Page 13 / 13

Quick answer

This filtered view shows 302 pharmaceutical patents matching "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

302 results for “TEVA PHARMACEUTICAL INDUSTRIES, LTD.” · 30,257 patents in full index Clear search

  1. US 6462222

    Aminoindan derivatives

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 8, 2002 · Expires Oct 3, 2022

    expired
  2. US 6452054

    Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 17, 2002 · Expires Sep 12, 2022

    expired
  3. US 6376545

    Dispersible compositions containing L-DOPA ethyl ester

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 23, 2002 · Expires Apr 18, 2022

    expired
  4. US 6365574

    Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 2, 2002 · Expires Mar 28, 2022

    expired
  5. US 6316504

    Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 13, 2001 · Expires Nov 8, 2021

    expired
  6. US 6303650

    Aminoindan derivatives

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 16, 2001 · Expires Oct 11, 2021

    expired
  7. US 6281381

    Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 28, 2001 · Expires Aug 23, 2021

    expired
  8. US 6277886

    Pharmaceutical compositions comprising S-(-)-N-propargyl-1-aminoindan

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 21, 2001 · Expires Aug 16, 2021

    expired
  9. US 6271263

    Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 7, 2001 · Expires Aug 2, 2021

    expired
  10. US 6248888

    Process for the preparation of terazosin hydrochloride dihydrate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 19, 2001 · Expires Jun 14, 2021

    expired
  11. US 6218566

    Process for manufacturing of L-DOPA ethyl ester

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 17, 2001 · Expires Apr 12, 2021

    expired
  12. US 6201148

    Process for preparing alendronic acid

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 13, 2001 · Expires Mar 8, 2021

    expired
  13. US 6126968

    Stable compositions containing N-propargyl-1-aminoindan

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 3, 2000 · Expires Sep 28, 2020

    expired
  14. US 6127426

    10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 3, 2000 · Expires Sep 28, 2020

    expired